During the past decade, Santa Barbara Hematology Oncology Medical Group, Inc. conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Santa Barbara Hematology Oncology Medical Group, Inc." #1 sponsor was "Translational Oncology Research International" with 4 trials, followed by "NSABP Foundation Inc" with 2 trials sponsored, "Agennix" with 1 trials sponsored, "Antisoma Research" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Santa Barbara Hematology Oncology Medical Group, Inc." #1 collaborator was "Genentech, Inc." with 5 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Santa Barbara Hematology Oncology Medical Group, Inc." are "Breast Cancer" (4 trials), "Prostate Cancer" (3 trials), "Colonic Neoplasms" (2 trials), "Colorectal Cancer" (2 trials) and "Colorectal Neoplasms" (2 trials). Many other conditions were trialed in "Santa Barbara Hematology Oncology Medical Group, Inc." in a lesser frequency.

Most popular intervention types in "Santa Barbara Hematology Oncology Medical Group, Inc." are "Drug" (19 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (3 trials), "Bevacizumab" (2 trials), "Trastuzumab" (2 trials), "Vatalanib" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Santa Barbara Hematology Oncology Medical Group, Inc." are 12 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Santa Barbara Hematology Oncology Medical Group, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Santa Barbara Hematology Oncology Medical Group, Inc., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Santa Barbara Hematology Oncology Medical Group, Inc., 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".